Published in Diabetes Week, October 20th, 2003
"A novel series of orally active pyrimido[5,4-3][1,2,4]triazine-5,7-diamine-based hypoglycemic agents have been identified. These compounds show non-selective inhibitory properties against a panel of protein tyrosine phosphatases including PTP1B," researchers in the United States report.
Two of the compounds were capable of lowering oral glucose in ob/ob mice, reported Kevin R. Guertin and colleagues at Aventis Pharmaceuticals.
Guertin and his...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.